海峡药学
海峽藥學
해협약학
STRAIT PHARMACEUTICAL JOURNAL
2015年
4期
84-85,86
,共3页
血必清%感染性休克%血清降钙素原
血必清%感染性休剋%血清降鈣素原
혈필청%감염성휴극%혈청강개소원
Xuebijing%Septic shock%PCT
目的:探讨血必净注射液在治疗感染性休克的效果及对血清降钙素原( PCT)及CRP水平的影响。方法选取2013年4月~2014年10月我院收治的252例感染性休克作为研究对象,将患者随机分为研究组和对照组,各126例。对照组患者使用常规治疗,观察组患者在常规治疗基础上使用血必净静脉滴注治疗。综合比较两组患者治疗总有效率、治疗前后血清PCT、CRP值及不良反应发生率的差异。结果研究组治疗总有效率为89.7%,显著高于对照组的78.6%(P<0.05);治疗后研究组患者血清PCT、CRP值均显著优于对照组(P<0.05);两组均无严重不良反应( P>0.05)。结论血必净注射液治疗感染性休克疗效确切,可显著降低血清PCT、CRP水平,无严重不良反应。
目的:探討血必淨註射液在治療感染性休剋的效果及對血清降鈣素原( PCT)及CRP水平的影響。方法選取2013年4月~2014年10月我院收治的252例感染性休剋作為研究對象,將患者隨機分為研究組和對照組,各126例。對照組患者使用常規治療,觀察組患者在常規治療基礎上使用血必淨靜脈滴註治療。綜閤比較兩組患者治療總有效率、治療前後血清PCT、CRP值及不良反應髮生率的差異。結果研究組治療總有效率為89.7%,顯著高于對照組的78.6%(P<0.05);治療後研究組患者血清PCT、CRP值均顯著優于對照組(P<0.05);兩組均無嚴重不良反應( P>0.05)。結論血必淨註射液治療感染性休剋療效確切,可顯著降低血清PCT、CRP水平,無嚴重不良反應。
목적:탐토혈필정주사액재치료감염성휴극적효과급대혈청강개소원( PCT)급CRP수평적영향。방법선취2013년4월~2014년10월아원수치적252례감염성휴극작위연구대상,장환자수궤분위연구조화대조조,각126례。대조조환자사용상규치료,관찰조환자재상규치료기출상사용혈필정정맥적주치료。종합비교량조환자치료총유효솔、치료전후혈청PCT、CRP치급불량반응발생솔적차이。결과연구조치료총유효솔위89.7%,현저고우대조조적78.6%(P<0.05);치료후연구조환자혈청PCT、CRP치균현저우우대조조(P<0.05);량조균무엄중불량반응( P>0.05)。결론혈필정주사액치료감염성휴극료효학절,가현저강저혈청PCT、CRP수평,무엄중불량반응。
ABSTRACT:OBJECTIVE To investigate effects of Xuebijing injection for the treatment of septic shock and the influenceofPCTandCRPlevels.METHODS 126casesofsepticshockpatientsinourhospitalwererandomlydi-vided into research group and control group,each were 63 cases.Research group were treated with Xuebijing intrave-nous injection treatment based on conventional therapy.Control group were treated with conventional therapy on-ly.Total effective rate,PCT and CPR before and after treatment,adverse reaction rate were compared.RESULTS The total effective rate of research group were 89.7%,which was higher than control group.The PCT and CRP of re-search group after treatment were better than control group ( P<0.05).There was no serious adverse reaction in the? 84? <br> two groups (P>0.05).CONCLUSION Xuebijing has exact effect for septic shock.It can reduce PCT and CRP levels significantly and has no serious adverse reaction.